Page last updated: 2024-10-29

isradipine and Cardiovascular Diseases

isradipine has been researched along with Cardiovascular Diseases in 7 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"The administration of isradipine did not significantly modify AMS symptom score nor most of other parameters measured in high altitude hypoxia."5.08[Cardiovascular effects of a calcium channel blocker in hypoxia caused by altitude]. ( Court-Payen, M; Dubray, C; Dugas, L; Hansen, JM; Herry, JP; Olsen, NV; Richalet, JP; Robach, P; Ter-Minassian, A, 1995)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dugas, L1
Dubray, C1
Herry, JP1
Olsen, NV1
Court-Payen, M1
Hansen, JM1
Robach, P1
Ter-Minassian, A1
Richalet, JP1
Madren, EM1
Byington, RP2
Furberg, CD2
Craven, TE2
Pahor, M2
Sowers, JR1
Mason, RP1
Mason, PE1
Fitton, A1
Benfield, P1

Reviews

2 reviews available for isradipine and Cardiovascular Diseases

ArticleYear
Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.
    Diabetes care, 1999, Volume: 22, Issue:7

    Topics: Calcium Channel Blockers; Cardiovascular Diseases; Diabetic Angiopathies; Humans; Hypertension; Isra

1999
Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease.
    Drugs, 1990, Volume: 40, Issue:1

    Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Humans; Isradipine; Pyridines

1990

Trials

3 trials available for isradipine and Cardiovascular Diseases

ArticleYear
[Cardiovascular effects of a calcium channel blocker in hypoxia caused by altitude].
    Presse medicale (Paris, France : 1983), 1995, Apr-29, Volume: 24, Issue:16

    Topics: Adult; Altitude Sickness; Capillary Permeability; Cardiovascular Diseases; Color Perception; Double-

1995
Isradipine in prediabetic hypertensive subjects.
    Diabetes care, 1998, Volume: 21, Issue:12

    Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Dis

1998
Isradipine, raised glycosylated haemoglobin, and risk of cardiovascular events.
    Lancet (London, England), 1997, Oct-11, Volume: 350, Issue:9084

    Topics: Arteriosclerosis; Blood Glucose; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Artery D

1997

Other Studies

2 other studies available for isradipine and Cardiovascular Diseases

ArticleYear
Vascular events during antihypertensive treatment.
    The Journal of family practice, 1996, Volume: 43, Issue:6

    Topics: Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Stenosis; Diuret

1996
Antihypertensive treatment: prevention of cardiovascular disease and prevention of events. Satellite symposium to the 5th European Meeting on Hypertension. Milan, Italy, June 7-10, 1991.
    Journal of cardiovascular pharmacology, 1992, Volume: 19 Suppl 3

    Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Dihydropyridines; Humans; Isradipine

1992